Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Optimization of M3 Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD.
Journal: Journal of medicinal chemistry
Published: August 10, 2023
Discovery of M3 Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease.
Journal: Journal of medicinal chemistry
Published: June 18, 2021
Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis.
Journal: Bioorganic & medicinal chemistry letters
Published: December 20, 2011
Showing 1-3 of 3
Last Updated: 09/26/2026